| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |